GEHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GE Healthcare Technologies Inc is not a strong buy at the moment for a beginner investor with a long-term focus. While the company operates in a growing sector and has potential positive catalysts, its recent financial performance shows declining net income, EPS, and gross margin. Additionally, hedge funds are selling, and analysts have been lowering price targets. The lack of strong trading signals and neutral technical indicators suggest waiting for a better entry point.
The MACD is positive but contracting, RSI is neutral at 54.077, and moving averages are converging, indicating no clear trend. Key support is at 69.852, and resistance is at 74.543. The stock closed at 73.63, near its resistance level, with no strong momentum.
The U.S. cardiovascular devices market is projected to grow significantly, and 75% of U.S. health systems are adopting AI-powered clinical tools, which aligns with GEHC's business focus.
Hedge funds are selling significantly, and analysts have been consistently lowering price targets. The company's financial performance shows declining net income, EPS, and gross margin.
In Q4 2025, revenue increased by 7.13% YoY to $5.698 billion, but net income dropped by 18.31% YoY to $589 million. EPS declined by 17.83% YoY to 1.29, and gross margin fell by 7.22% YoY to 39.68%.
Analysts have been lowering price targets recently, with the latest targets ranging from $80 to $90. Most ratings are Buy or Outperform, but some are Neutral, reflecting mixed sentiment. The medical technology sector is facing multiple compression and cautious outlooks ahead of Q1 earnings.
